FDA Clears AI-Powered Device for Monitoring Surgical Effluent

It's designed to continuously provide care teams with real-time pH data.

Screenshot 2025 11 05 At 9 19 15 Am
FluidAI

Canadian medtech company FluidAI said the FDA has granted 510(k) clearance for Origin, an inline sensing system that provides bedside monitoring of surgical effluent for patients in a post-operative setting.

Origin can work as a standalone device but it's planned to be integrated with FluidAI’s Stream Care. The device has been designed to connect to standard surgical drains and continuously provide care teams with real-time pH data visualization at the bedside.

Backed by strategic collaborations with global healthcare providers, government agencies, and leading research consortiums, the company said it is actively expanding the reach of its solutions across North America, Europe, and the Middle East with this clearance.

More in Surgical